Parametric Portfolio Associates’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-56,936
| Closed | -$7.76M | – | 4060 |
|
|
2020
Q3 | $7.76M | Buy |
56,936
+9,988
| +21% | +$1.06M | 0.01% | 1561 |
|
|
2020
Q2 | $4.54M | Sell |
46,948
-3,112
| -6% | -$260K | ﹤0.01% | 1941 |
|
|
2020
Q1 | $2.35M | Buy |
50,060
+9,319
| +23% | +$597K | ﹤0.01% | 2273 |
|
|
2019
Q4 | $2.97M | Buy |
40,741
+15,303
| +60% | +$928K | ﹤0.01% | 2419 |
|
|
2019
Q3 | $1.33M | Buy |
25,438
+11,461
| +82% | +$609K | ﹤0.01% | 2875 |
|
|
2019
Q2 | $701K | Buy |
13,977
+3,801
| +37% | +$185K | ﹤0.01% | 3225 |
|
|
2019
Q1 | $529K | Sell |
10,176
-8,966
| -47% | -$413K | ﹤0.01% | 3311 |
|
|
2018
Q4 | $935K | Buy |
19,142
+11,752
| +159% | +$647K | ﹤0.01% | 3024 |
|
|
2018
Q3 | $482K | Buy |
7,390
+440
| +6% | +$25.9K | ﹤0.01% | 3428 |
|
|
2018
Q2 | $345K | Sell |
6,950
-19,775
| -74% | -$957K | ﹤0.01% | 3504 |
|
|
2018
Q1 | $1.3M | Buy |
26,725
+21,271
| +390% | +$1.11M | ﹤0.01% | 2873 |
|
|
2017
Q4 | $230K | Sell |
5,454
-23,602
| -81% | -$910K | ﹤0.01% | 3702 |
|
|
2017
Q3 | $1.25M | Buy |
+29,056
| New | +$927K | ﹤0.01% | 2903 |
|
Parametric Portfolio Associates's MYOK Position: Q4 2020 in Review
Parametric Portfolio Associates sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 56,936 shares — an estimated $7.76M sold.
Parametric Portfolio Associates first reported a position in MYOK in Q3 2017 and held it in 13 quarters. The position peaked at $7.76M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Parametric Portfolio Associates reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Parametric Portfolio Associates sold 56,936 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $7.76M.
- Parametric Portfolio Associates first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 13 quarters.
- Parametric Portfolio Associates's MyoKardia, Inc. Common Stock position peaked at $7.76M in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Parametric Portfolio Associates's 13F filing for Q4 2020, filed 12 Feb 2021.